Webseite regulanet.com

"Stay-at-home Economy" is a booming economic activity that focuses on moving, various exercises and physical training without going out. Currently, Deng Shuenn Industrial Co., Ltd has improved the practical efficiency of auxiliary sport equipment, such as the Crazy Fit Massager, Vibration plate training machine and so forth by study from domestic and foreign scholars. It is an alternative choice for those who do not have time for taking exercises, just like white collar workers, SOHO, old-aged and people who find it inconvenient to go outdoors.

Index Ventures today announced that Dr Kevin Johnson has formally expanded his relationship with the firm and has joined the team as a Partner in the Life Sciences team. Dr Johnson will focus specifically on seeking out new assets in the biologics area, which will enable Index Ventures to build companies based on the asset-centric model he and Index pioneered.

MSD (in den USA und Kanada unter dem Namen Merck bekannt) (NYSE:MRK) und Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) gaben heute bekannt, dass die intravenös (IV) verabreichte Formulierung von BRINAVESS™ (Vernakalant) die Marktzulassung in der Europäischen Union (EU), Island und Norwegen für die Konversion von kürzlich begonnenem Vorhofflimmern (VHF bzw. AF) in Sinusrhythmus bei erwachsenen Patienten erhalten hat.

Research and Markets (http://www.researchandmarkets.com/research/ebf598/norway_pharmaceuti) has announced the addition of the "Norway Pharmaceutical Market Analysis, 2010-2014" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/aaaafa/daily_updates_inf) has announced the addition of the "Daily Updates: Inflammatory Diseases - Tracking breaking research, drug development news new trials" subscription to their offering.

Research and Markets (http://www.researchandmarkets.com/research/886118/trends_in_generics) has announced the addition of the "Trends in Generics Industry Ownership: Evaluating Changing Industry Paradigms and Emerging Players" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/a3d4d9/daily_updates_can) has announced the addition of the "Daily Updates: Cancer Immunotherapy - Tracking breaking research, drug development news new trials" subscription to their offering.

Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on Wednesday, September 15, 2010 at 11:40 am Eastern time.

The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with Lytixar^TM (LTX-109) treatment of skin infections caused by Gram positive bacteria.

Market Publishers Ltd informs that new in-demand market reports by GlobalData are available in its catalogue.

Research and Markets (http://www.researchandmarkets.com/research/bca76e/health_grants_info) has announced the addition of the "Health Grants Information Service" subscription to their offering.

Research and Markets (http://www.researchandmarkets.com/research/857fc2/motion_sickness_th) has announced the addition of the "Motion Sickness Therapy Area Pipeline Report" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/2745c9/argentina_pharmace) has announced the addition of the "Argentina Pharmaceuticals and Healthcare Report Q4 2010" report to their offering.

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg. Financial terms of the transaction were not disclosed.

Covidien (NYSE: COV), ein führender weltweiter Anbieter medizinischer Produkte, meldete heute den Abschluss des zuvor angekündigten Verkaufs der Produkte für Schlaftherapien, für kontinuierlichen Atemwegsüberdruck (Continuous Positive Airway Pressure - CPAP) sowie der Bi-Level-Produkte an PH Invest, eine im Privatbesitz stehende Gesellschaft in Luxemburg. Finanzielle Details der Transaktion wurden nicht bekannt gegeben.

Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that its PLX cell therapy product, derived from human placenta, a non-controversial, non-embryonic, adult stem cell source, was selected as the only cell therapy product candidate to enter into a study seeking treatments for diastolic heart failure (DHF) in the European Commission's Seventh Framework Program (FP7). Pluristem is to receive a grant from the FP7 to cover study related R&D expenses.

Research and Markets (http://www.researchandmarkets.com/research/9846c1/target_product_pro) has announced the addition of Decision Resources, Inc.'s new report "Target Product Profiles 2010: Physician Insights on Key Attributes: Diabetic Neuropathy" to their offering.

Research and Markets (http://www.researchandmarkets.com/research/37adf0/eli_lilly_co_p) has announced the addition of the "Eli Lilly & Co.: PharmaVitae Profile" company profile to their offering.

Research and Markets (http://www.researchandmarkets.com/research/aabcf1/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering.

Research and Markets (http://www.researchandmarkets.com/research/a9fe9d/novartis_ag_pharm) has announced the addition of the "Novartis AG: PharmaVitae Profile" company profile to their offering.

Research and Markets (http://www.researchandmarkets.com/research/ac67d7/glaxosmithkline_pl) has announced the addition of the "GlaxoSmithKline plc: PharmaVitae Profile" company profile to their offering.

Research and Markets (http://www.researchandmarkets.com/research/d8a430/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Market Analysis, 2010-2014" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/3ceeca/japan_pharmaceutic) has announced the addition of the "Japan Pharmaceutical Market Analysis, 2010-2014" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/b87073/sweden_pharmaceuti) has announced the addition of the "Sweden Pharmaceutical Market Analysis, 2010-2014" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/5f5e15/asiapacific_pharm) has announced the addition of the "Asia-Pacific Pharmaceutical Market Analysis, 2010-2014" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/026583/chronic_obstructiv) has announced the addition of the "Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/df6207/onychomycosis_ther) has announced the addition of the "Onychomycosis Therapy Area Pipeline Report" report to their offering.

Maven Semantic (http://www.mavensemantic.com) announces updates to their Dermatology research database.

Research and Markets (http://www.researchandmarkets.com/research/60ef74/argentina_surgical) has announced the addition of GlobalData's new report "Argentina Surgical Equipment Market Outlook to 2016" to their offering.

Research and Markets (http://www.researchandmarkets.com/research/722116/taiwan_surgical_eq) has announced the addition of GlobalData 's new report "Taiwan Surgical Equipment Market Outlook to 2016" to their offering.

Research and Markets (http://www.researchandmarkets.com/research/895218/the_top_10_cardiov) has announced the addition of the "The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/d141a8/strategies_for_man) has announced the addition of the "Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of Legal, Productivity, and Quality Control Issues" report to their offering.

Research and Markets (http://www.researchandmarkets.com/research/aa6d13/health_care_equipm) has announced the addition of the "Health Care Equipment & Supplies: Global Industry Guide" report to their offering.

Elan Corporation, plc ("Elan") (NYSE: ELN) announced today that Elan's wholly-owned subsidiaries, Elan Finance public limited company ("Elan Finance") and Elan Finance Corp. ("Elan Corp" and together with Elan Finance, the "Issuers"), commenced an offer to purchase of up to $186,000,000 aggregate principal amount of their 8 7/8% Senior Fixed Rate Notes due 2013 (the "2013 Fixed Rate Notes") and their Floating Rate Notes Due 2013 (the "2013 Floating Rate Notes" together with the 2013 Fixed Rate Notes, the "2013 Notes"), in accordance with the terms of the indenture governing the 2013 Notes, at a purchase price of 100% of the principal amount thereof, plus accrued and unpaid interest to the date of payment. The offer will expire at 11:59 p.m., New York City time, on September 29, 2010, unless extended, and is expected to close on September 30, 2010.

Research and Markets (http://www.researchandmarkets.com/research/676ba5/industry_solutions) has announced the addition of the "Industry Solutions Guide: Selecting an Ambulatory EHR Vendor in the Healthcare Market (Competitor Focus)" report to their offering.